MolecularHealth Enters Boston Market
With the opening of a new office in the Boston metro area, MolecularHealth continues growth in preparation for the launch of its molecular diagnostic platform for cancer care.
Read More
Search Results for: genetic testing
Whole-Genome Sequencing for Clinical Use Faces Many Challenges, Study Finds
Researchers at Stanford University have discovered that although life-changing discoveries can be made using whole-genome sequencing, significant challenges must be overcome before the approach can be clinically useful on a routine basis.
Read More
Companion Diagnostics
Companion diagnostics provide information about a patient’s genetic and genomic characteristics to guide decisions about treatment with specific drugs. In this article from the March issue of CLP, contributing writer Gary Tufel examines how this relatively recent phenomenon is spawning a significant increase in pharmaceutical companies partnering with diagnostics firms to develop and produce such diagnostics—and thus more targeted and effective treatments.
Read MoreMyriad Publishes Clinical Utility Study for Prolaris
Data from the Procede 500 study of cell-cycle progression testing with the Prolaris RNA-expression test indicate that 65% of physicians changed their original treatment plans for men with prostate cancer based on results from the test.
Read More
RainDance Technologies Closes Series E Financing with GE Ventures
Genomics tools company RainDance Technologies has closed a $16.5 million financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in the round.
Read More